Bronstein, Gewirtz & Grossman, LLC Announces Enovix Corporation (ENVX) Investigation

NEW YORK, Dec. 7, 2022 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Enovix Corporation ("Enovix" or the "Company") (NASDAQ: ENVX). Investors who purchased Enovix securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/envx.

The investigation concerns whether Enovix violated federal securities laws.

On November 1, 2022, Enovix announced its 2022 third-quarter financial results, which were significantly below analyst expectations. Among other items, Enovix reported a net loss of $23.2 million, or $.15 per share, and stated that "[t]he majority of batteries shipped during the quarter were samples that did not generate revenue." On this news, Enovix's stock price fell $7.46 per share, or 41.47%, to close at $10.53 per share on November 2, 2022.

If you are aware of any facts relating to this investigation or purchased Enovix securities, you can assist this investigation by visiting the firm's site: www.bgandg.com/envx. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]

SOURCE Bronstein, Gewirtz & Grossman, LLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED